PharmEnable Therapeutics Alternatives & Competitors
12 companies similar to PharmEnable Therapeutics — Harnessing the power of chemical novelty, diversity and 3-dimensionality to deve...
Companies similar to PharmEnable Therapeutics
Frontier Medicines
Frontier Medicines is a biopharmaceutical company that “drugs the undruggable” to transfor...
South San Francisco, Unit...
858 Therapeutics
Discovering innovative small molecule therapeutics for the treatment of cancer
San Diego, United States
TenSixty Biosciences
We're on a mission to create transformative drugs that will save lives and redefine oncolo...
Rgenta Therapeutics Inc.
We unlock the therapeutic potentials of highly disease-relevant targets undruggable by sma...
Woburn, United States
Rival Readout
Competing with PharmEnable Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Integrated Biosciences, Inc.
Unravelling complex biology with optogenetics, chemistry and computation for small molecul...
Redwood City, United Stat...
Terray Therapeutics
Everything small molecule drug discovery should be.
Pasadena, United States
Bresso, Italy
Arrakis Therapeutics
Arrakis is on a path to bring powerful new RNA-targeted small molecule (rSM) therapies to...
Waltham, United States
Redx Pharma
Biotech company focusing on the discovery and development of novel targeted medicines to t...
United Kingdom
Flare Therapeutics
Trailblazing the path to drugging transcription factors to discover precision medicines fo...
Cambridge, United States
About PharmEnable Therapeutics
PharmEnable Therapeutics, founded in 2016, is a pioneering biopharmaceutical company operating at the cutting edge of Biotechnology, Life Sciences, and Pharmaceutical industries. Based in the United Kingdom and a spin-off from the University of Cambridge, the company is renowned for its slogan: "Harnessing the power of...
AI-driven drug discovery, Development of small molecule drugs, Therapeutic target identification, Pipeline development
Pharmaceutical companies, Biotechnology firms, Medical researchers, Healthcare providers
AI-enabled Drug Discovery, Small Molecule Drugs, Chemical Novelty, 3D Chemical Space Exploration, Oncology Therapeutics, Neurology Therapeutics, Proprietary AI Platform, ChemSEEK, Antibody-like Specificity, Drug Discovery Partnerships, University Of Cambridge Spinoff, Inaccessible Disease Targets
B2B, Platform, B2B2B
Licensing, Service Fee, Project Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around PharmEnable Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at PharmEnable Therapeutics on 11 Mar 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 21 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
